Publication:
Prevalence, Treatment, and Associated Factors of Hypertension in Spain: A Comparative Study between Populations

dc.contributor.authorCorbatón-Anchuelo, Arturo
dc.contributor.authorMartínez-Larrad, María Teresa
dc.contributor.authorDel Prado-González, Náyade
dc.contributor.authorFernández-Pérez, Cristina
dc.contributor.authorGabriel-Sanchez, Rafael
dc.contributor.authorSerrano-Ríos, Manuel
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderComunidad de Madrid (España)
dc.date.accessioned2020-04-29T07:35:59Z
dc.date.available2020-04-29T07:35:59Z
dc.date.issued2018
dc.description.abstractThe prevalence and related factors of hypertensive subjects according to the resident area (rural versus urban) were investigated in two population-based studies from Spain. Medical questionnaires were administered and anthropometrics were measured, using standardized protocols. Hypertension was diagnosed in pharmacology treated subjects or those with blood pressure (BP) ≥140/90 mm Hg. Regarding BP control, it was defined as under control if BP was <140/90 or <140/85 mm Hg in type 2 diabetic subjects. Information on educational status, social class, smoking habit, and alcohol intake was obtained. 3,816 subjects (54.38 % women) were included. Prevalence of diagnosed hypertension was higher in women and showed no differences according to the living area (men: urban 21.88 versus rural 21.92 %, p = 0.986; women: urban 28.73 versus rural 30.01 %, p = 0.540). Women living in rural areas and men with secondary or tertiary education levels had a lower probability of being BP uncontrolled (OR (95 % CI): 0.501 (0.258-0.970)/p=0.040, 0.245 (0.092-0.654)/p=0.005, and 0.156 (0.044-0.549)/p=0.004, respectively). Urban young men (31-45 years) and medium aged women (46-60 years) were less BP controlled than their rural counterparts (41.30 versus 65.79 %/p=0.025 and 35.24 versus 53.27 %/p=0.002, respectively).es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by Grants FEDER 2FD 1997/2309 from the Fondo Europeo para el Desarrollo Regional, Red de Centros RCMN (C03/08), FIS 03/1618 from Instituto de Salud Carlos III-RETIC RD06/0015/0012, Madrid, Spain. The authors also acknowledge CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovación) and Madrid Autonomous Community (MOIR S2010/BMD-2423). Partial support also came from Educational Grants from Eli Lilly Lab, Spain, Bayer Pharmaceutical Co., Spain and Fundación Mutua Madrileña 2008, Spain. Members of the Segovia Insulin Resistance Study Group are acknowledged. The authors also acknowledge Milagros Pérez-Barba for dedicated and careful technical assistance.es_ES
dc.format.page4851512es_ES
dc.format.volume2018es_ES
dc.identifier.citationInt J Hypertens. 2018 Aug 14;2018:4851512.es_ES
dc.identifier.doi10.1155/2018/4851512es_ES
dc.identifier.issn2090-0384es_ES
dc.identifier.journalInternational journal of hypertensiones_ES
dc.identifier.pubmedID30186629es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9794
dc.language.isoenges_ES
dc.publisherSAGE, Hindawi Access to Research
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/FEDER 2FD 1997/2309es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/PI03/1618es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/RD06/0015/0012es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/MOIR S2010/BMD-2423es_ES
dc.relation.publisherversionhttps://doi.org/10.1155/2018/4851512es_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titlePrevalence, Treatment, and Associated Factors of Hypertension in Spain: A Comparative Study between Populationses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication2a4245cf-fbe4-49f6-b2fa-444c7a813c0c
relation.isAuthorOfPublication.latestForDiscovery2a4245cf-fbe4-49f6-b2fa-444c7a813c0c
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication20a4976f-6e59-4606-96a5-c6eb961b4ebc
relation.isPublisherOfPublication.latestForDiscovery20a4976f-6e59-4606-96a5-c6eb961b4ebc

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PrevalenceTreatmentAndAssociated_2018.pdf
Size:
1.64 MB
Format:
Adobe Portable Document Format
Description: